BlackRock’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-187,700
Closed -$13.9M 5520
2023
Q1
$13.9M Sell
187,700
-661,100
-78% -$55.4M ﹤0.01% 3149
2022
Q4
$79.1M Buy
+848,800
New +$81.9M ﹤0.01% 2166
2020
Q2
Sell
-426,700
Closed -$25.3M 5023
2020
Q1
$25.3M Buy
+426,700
New +$28.5M ﹤0.01% 2481
2019
Q3
Sell
-400,000
Closed -$21.8M 4987
2019
Q2
$21.8M Buy
+400,000
New +$21.5M ﹤0.01% 2793

Other funds holding CVS

BlackRock's CVS Position: Q2 2026 in Review

BlackRock reduced its CVS Health (CVS) stake by 2.1% in Q2 2026, selling an estimated $241M and leaving 123,223,409 shares worth $12.7B. The position accounts for 0.19% of the portfolio, ranked #80.

BlackRock first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • BlackRock held 123,223,409 shares of CVS Health worth $12.7B as of Q2 2026.
  • BlackRock sold 2,696,444 CVS Health shares in Q2 2026, an estimated $241M.
  • CVS Health made up 0.19% of BlackRock's portfolio in Q2 2026, its #80 holding.
  • BlackRock first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.